Sulforaphane-conjugated selenium nanoparticles: towards a synergistic anticancer effect

Area of Science:

• Nanotechnology
• Biochemistry
• Materials Science

Background:

• Selenium nanoparticles (SeNPs) are explored for biomedical applications.
• Sulforaphane (SFN) is a natural compound with anticancer properties.
• Combining SFN with SeNPs may enhance therapeutic efficacy.

Purpose of the Study:

• To synthesize and characterize sulforaphane-modified selenium nanoparticles (SFN-SeNPs).
• To evaluate the in vivo biodistribution and safety of SFN-SeNPs.
• To investigate the in vitro anticancer activity and selectivity of SFN-SeNPs.

Main Methods:

• Aqueous-phase redox reaction using selenite and ascorbic acid for SeNP synthesis.
• Adsorption of sulforaphane onto the SeNP surface.
• Physicochemical characterization using microscopy, spectroscopy, XRD, DLS, and zeta potential.
• In vivo studies in rats for biodistribution and safety assessment.
• In vitro cytotoxicity assays on cancer and normal cell lines.

Main Results:

• SFN-SeNPs were successfully prepared and characterized.
• In vivo studies showed SFN-SeNPs are eliminated mainly via urine, with some retention in the liver, while maintaining normal blood and urine parameters.
• In vitro studies demonstrated significant anticancer activity of SFN-SeNPs against cancer cells.
• SFN-SeNPs exhibited low cytotoxicity towards normal cells.

Conclusions:

• Sulforaphane-modified selenium nanoparticles exhibit synergistic anticancer effects.
• The SFN-SeNP conjugate shows promising antitumor activity and selectivity.
• These findings suggest SFN-SeNPs are a potential candidate for cancer therapy.